Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …

Abstract Background: Research in the United States and Europe has found that women
have an advantage over men in surviving a diagnosis of cancer, but the issue has not been …

Background Recent revision significantly changed the American Joint Committee on Cancer
(AJCC) staging criteria for differentiated thyroid cancer (DTC). To quantitatively evaluate …

Objectives: We aimed to investigate the prevalence of the BRAF (V600E) mutation in
consecutive cases of papillary thyroid carcinoma (PTC) in patients diagnosed and treated at …

The morbidity of thyroid cancer has been rising obviously throughout the world during the
past years. Classic treatment procedure is generally curable for low risk differentiated thyroid …

Background Incidences of thyroid cancer (TC) have been increasing worldwide in recent
decades. In this research, we aimed to analyze the spatiotemporal pattern of TC and explore …

Objective Differentiated thyroid cancer is rare, but the incidence has been increasing in the
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …

Background: In the world, there are approximately 160,000 cases of laryngeal cancer newly
diagnosed every year and 95% of the cases are squamous cell carcinoma (LSCC). We …

Background: Serum thyroid hormone concentration is regulated through the hypothalamic–
pituitary–thyroid axis. This study aimed to clarify the relationships between thyroid hormone …

Objectives Evaluate the impact of microscopic extrathyroid extension (MEE) on outcome and
therapy response in patients with cT1 and cT2 papillary thyroid carcinoma (PTC). Subjects …